Affimed Plans to Take Antibodies into Clinic with $26M Series C May 5, 2010 By Catherine Hollingsworth
Affimed Plans to Take Antibodies into Clinic with $26M Series C April 30, 2010 By Catherine Hollingsworth
Lycera's Progress Triggers $11M in Second Part of Series A Round April 29, 2010 By Catherine Hollingsworth
YM Could Bring in Up to $7.75M in Controlled Equity Financing April 28, 2010 By Catherine Hollingsworth
Garnet Seeking Additional Funds to Advance Lead Cell Therapy April 27, 2010 By Catherine Hollingsworth
